Matthew J. Ahearne

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Sean H. Lim, Beth Stuart, Débora Joseph‐Pietras et al. · Nature Cancer · 2022 · 87 citations · Full text

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Sean H. Lim, Nicola Campbell, Marina Johnson et al. · The Lancet Haematology · 2021 · 84 citations · Full text

Vaccination, Vaccine Development, Immunology +3

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Nicole Wong Doo, Carole Soussain, Sylvain Choquet et al. · UCL Discovery (University College London) · 2022 · 76 citations

Enhancement of <scp>CD</scp>154/<scp>IL</scp>4 proliferation by the <scp>T</scp> follicular helper (<scp>T</scp>fh) cytokine, <scp>IL</scp>21 and increased numbers of circulating cells resembling <scp>T</scp>fh cells in chronic lymphocytic leukaemia

Matthew J. Ahearne, Shaun Willimott, Lucia Piñon et al. · British Journal of Haematology · 2013 · 69 citations · Full text

Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma

Matthew J. Ahearne, Kaljit Bhuller, Roger Hew et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2014 · 66 citations

Tumor Biology, Lymphoid Neoplasia, Immunology +5